Skip to content

Clinical trials

Asthma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Country / region: China Clear all

214 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20081
20093
20107
20113
20129
20135
20146
201512
20168
201712
20188
20197
20208
202115
202218
202319
202431
202527
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed99
Unknown status44
Recruiting42
Not yet recruiting11
Active, not recruiting6
Terminated6
Enrolling by invitation5
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca23
GlaxoSmithKline15
Guangzhou Institute of Respiratory Disease9
Second Affiliated Hospital, Zhejiang University, School of Medicine8
Shanghai University of Traditional Chinese Medicine7
Novartis Pharmaceuticals6
Sanofi5
Shanghai Children's Medical Center5
Beijing Chao Yang Hospital4
First Affiliated Hospital of Ningbo University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma214
Pulmonary Disease, Chronic Obstructive20
Rhinitis, Allergic11
Dermatitis, Atopic7
Bronchiectasis6
Hypersensitivity6
Disease5
Cough-Variant Asthma4
Lung Diseases4
Pulmonary Eosinophilia4

Trials

Showing 51 to 75 of 214. Each trial links to its page on Pharma Observatory.

114 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.